Taub Rebecca
SEC Form 4 insider trading activity
Taub Rebecca has filed 8 SEC Form 4 filings (61 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Jun 18, 2026.
On the most recent filing, Taub Rebecca is listed as Director at MADRIGAL PHARMACEUTICALS, INC. Inside the rolling window, Taub Rebecca reported no open-market purchases and 5 open-market sales totaling $21.7M in MDGL. The largest disclosed transaction in the window is a sale of 18,650 MDGL shares on Dec 10, 2025, worth $10.3M.
Companies traded
Other insiders at MDGL
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$21.7M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Taub Rebecca made?
Taub Rebecca has filed 8 SEC Form 4 filings (61 transaction rows) across 1 company since 2025.
Which companies does Taub Rebecca trade?
Taub Rebecca has filed SEC Form 4 disclosures for 1 company, including MDGL.
When was Taub Rebecca's most recent SEC Form 4 filing?
Taub Rebecca's most recent SEC Form 4 filing on Tracefour is dated Jun 18, 2026.
What is Taub Rebecca's total buy and sell value in the current window?
Inside the rolling retention window, Taub Rebecca bought $0 and sold $21.7M based on SEC Form 4 filings.
What was Taub Rebecca's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 18,650 MDGL shares on 2025-12-10, worth $10.3M, per SEC Form 4 filings.